Dr. Atay Vural has been awarded a stipend by the Alexander von Humboldt Foundation to spend time in the group of Prof. Edgar Meinl to conduct research into MOG-Ak, which is part of the work done in the CRC-TR128 B08 project. After Dr. Vural’s stay in Prof. Meinl’s group, he will return to his home country of Turkey, where he will employ the techniques learnt in Germany in further research projects.
Sarah Laurent und Franziska Thaler, scientists working on the B08 project of the CRC TR128, have been awarded the Helmut Bauer Prize 2015 for young researchers for their work on the survival, regulation and activation of B cells in multiple sclerosis (see publications below). More information on this prize can be found in this press release (in German).
Laurent et al. γ-Secretase directly sheds the survival receptor BCMA from plasma cells Nat Commun 2015 6:7333
Hoffmann et al. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity J Immunol 2015 194(2):542-52
Prof. Heinz Wiendl, Co-Speaker of the CRC-TR-128, has been awarded the prestigious Sobek Research Prize 2015 for his contributions to research into multiple sclerosis. More information can be found in this press release (in German)
You can read the associated article and listen to the interview on the Deutschland Funk website or using the player below.
Nina Wettschureck (MPI Bad Nauheim) from the CRC-TR-128, together with Markus Schwaninger (University of Lübeck), has been awarded the Novartis prize for therapy-relevant pharmacological research. The prize, which carries a value of €10,000, was presented at the Annual Conference of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) on 12 March 2015 in Kiel.
More details can be found in this press release, and the research for which the prize was awarded was reported in the following publication in The Journal of Clinical Investigation:
Congratulations to the CRC Scientists Nicholas Schwab and Johanna Breuer from the Neurological Clinic of the University Hospital Münster who were awarded the Helmut-Bauer Young-Scientist Prize for MS Research. (more…)
CRC scientists from the University Medical Center Mainz, together with colleagues from the University of Virginia, have identified a new mechanism that mediates repair of nerve cells after damage to the central nervous system. (more…)
From 9-13 November 2014, over 1000 neuroimmunologists from all over the world met at the 12th International Congress for Neuroimmunology in Mainz. (more…)
Congratulations to Dr. Nicholas Schwab and Dr. Tilman Schneider-Hohendorf, both from the Department of Neurology, University of Münster, who received prizes at two prestigious conferences recently! (more…)
Münster scientists: Even a highly efficacious MS drug cannot stop certain inflammatory cells (more…)